TAFFIC (Tenofovir & Emtricitabine & Biktegravir) is an antiretroviral drug containing three main factors; Tenofovir alafenamide emtricitabine biktegravir Tenofovir alafenamide biotegravir is a nucleotide transcriptase inhibitor Emtricitabine is a nucleoside reverse transcriptase inhibitor.
It is the most effective and powerful compound against HIV-1 infections, but it does not cure the infection situation, it is only used to prevent and suppress the evolution of HIV-1 infection into AIDS. In TAFFIC tablets, TAF is present as a prodrug. Emtricitabine is a synthetic fluorine derivative of thiacytodone. Bictegravir is an investigational drug.
TAFFIC is a combination tablet containing tenofovir alafenamide, emtricitabine and bictegravir, primarily intended for the treatment of HIV-1 infection in adult patients.